PharmaForce
PharmaForce provides 340B drug-pricing program administration. Its offerings include contract pharmacy, mixed-use/split billing, discount cards, and referral claim capture, delivered as software plus services. Customers are hospitals and other covered entities that want to cut 340B admin fees while keeping compliance strong. It is private equity-backed: Aquiline Capital Partners made a majority investment (reported Jan 2024). Tracxn counted about 368 employees as of May 2026. The company is a healthcare software and TPA business, and I found no evidence that it sells AI products.
Funding
Every round, secondary, debt facility or acquisition involving PharmaForce that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in